Wordt geladen...
The effect of federal and state off-label marketing investigations on drug prescribing: The case of olanzapine
In the past decade, the federal government has frequently investigated and prosecuted pharmaceutical manufacturers for illegal promotion of drugs for indications not approved by the Food and Drug Administration (FDA) (“off-label” uses). State governments can choose to coordinate with the federal inv...
Bewaard in:
| Gepubliceerd in: | PLoS One |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Public Library of Science
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5384770/ https://ncbi.nlm.nih.gov/pubmed/28388667 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0175313 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|